Status:
UNKNOWN
Short- Term Follow up Of Neonates Born With Neural Tube Defect
Lead Sponsor:
Hacettepe University
Conditions:
Neural Tube Defects
Newborn Morbidity
Eligibility:
All Genders
Up to 28 years
Brief Summary
Neural tube defects (NTD), which is the most common anomaly of the central nervous system, which can be diagnosed during antenatal period, brings many problems both in the neonatal period and in advan...
Detailed Description
Neural tube defects (NTD), which is the most common anomaly of the central nervous system, which can be diagnosed during antenatal period, brings many problems both in the neonatal period and in advan...
Eligibility Criteria
Inclusion
- Babies who have been hospitalized in the Neonatal Intensive Care Unit of Hacettepe University İhsan Dogramaci Children's Hospital and who have been operated due to neural tube defects will be taken.
Exclusion
- Patients whose file records cannot be reached will not be included.
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04760509
Start Date
February 1 2021
End Date
December 31 2021
Last Update
February 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Umit Ayse Tandircioglu
Ankara, Turkey (Türkiye), 06230